Patents Relate to Company’s Proprietary Prana Bio Nutrient Medicinals Targeting Disorders of the Nervous System, Immune System and Cancer
Denver, CO / ACCESSWIRE / October 28, 2014 / United Cannabis Corp. (OTCBB: CNAB) (the “Company” or “United Cannabis”) today announced that it has filed for provisional patents related to unique combinations of pharmaceutically active cannabinoids used to treat disorders of the nervous system, immune system and cancer, with the U.S. Patent and Trademark Office.
Using data derived from preclinical and clinical studies, United Cannabis’ research team has identified unique ratios and specifications of cannabinoids that can be used to target the underlying mechanisms of disorders such as PTSD, neuropathy and breast cancer.
Tony Verzura, United Cannabis Chief Technology Officer, commented, “Our focus is not on the treatment of symptoms of disease, but rather on reversing the underlying pathology that drives and contributes to specific disorders. These patents stem from that unique approach and the success we have seen for patients using our Prana products and A.C.T. Now Program.”
Earnie Blackmon, the Company’s Chief Executive Officer, further explains “United Cannabis is dedicated to exploring the role that cannabinoids can play in the field of regenerative medicine, with the goal of not only restoring a balance in physiology but also augmenting the body’s ability to regenerate and heal itself.”
About United Cannabis Corporation
United Cannabis Corporation was formed to advance the use of cannabinoids in medicine through research, product development and education. The Company is dedicated to improving the lives of patients through the creation of products using only the highest quality genetics, purest extractions and most effective protocols possible. The Company’s A.C.T. Now Program and patent-pending Prana Bio Nutrient Medicinals provide a comprehensive solution designed to enable physicians and patients to design, implement and monitor effective therapy protocols.
For further information, please visit www.unitedcannabis.us
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, and are subject to Rule 3B-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and other results and further events could differ materially from those anticipated in such statements. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.
Contact: Lorin Cohen
+1 (720) 319-7519
SOURCE: United Cannabis Corporation